|
|
|
|
Vol. 61, Issue 2, 277-284, February 2002
Departments of Neurosurgery (Y.K., K.N., N.H.) and Pharmacology (Y.K., Y.O., S.M., T.M.), Kyoto University Faculty of Medicine, Kyoto, Japan
| |
Abstract |
|---|
|
|
|---|
The purposes of the present study were to clarify the
significance of the palmitoylation site and the cytoplasmic tail of the
endothelinA receptor (ETAR) in coupling with G
proteins and to determine the subtypes of G protein that are involved
in actin stress-fiber formation in Chinese hamster ovary cells that
stably express ETAR (CHO-ETAR). For these
purposes, we constructed CHO cells stably expressing an
unpalmitoylated
(Cys383Cys385-388
Ser383Ser385-388)
ETAR (CHOSerETAR) and a series of
truncated ETARs that lacked the cytoplasmic tail downstream
of either of the five cysteine residues
(Cys383Cys385-388). All truncated
ETARs but not SerETAR failed to stimulate
adenylyl cyclase. With the truncated ETARs holding
Cys385, ET-1 stimulated formation of inositol phosphates,
but such stimulation failed with truncated ETARs lacking
Cys385. With wild-type ETARs, ET-1 induced
actin stress-fiber formation, which was inhibited by
(R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide (Y-27632), a Rho-associated coiled-coil-forming protein kinase (ROCK) inhibitor. The formation was unaffected by
1-(6-{[17
-3-methoxyestra-1,3.5(10)-trien-17-yl] amino}hexyl)-1Hpyrrole-2,5-dione
(U73122), a phospholipase C (PLC) inhibitor, or dominant
negative mutants of G12 (G12G228A) or
G13 (G13G225A), whereas it was inhibited by
U73122 in combination with G12G228A but not
G13G225A. Dibutyryl cAMP alone did not induce stress-fiber
formation. With unpalmitoylated or truncated ETARs, the
formation was sensitive to G12G228A or U73122,
respectively. These results indicate that 1) Cys385 of
ETAR is critical for coupling with Gq, 2) the
cytoplasmic tail downstream of the palmitoylation sites of
ETAR is essential for coupling with Gs and
G12, and 3) the signal for ET-1-induced stress-fiber
formation is transmitted through the Gq/PLC- and G12-dependent pathway to the Rho/ROCK system.
| |
Introduction |
|---|
|
|
|---|
Endothelin-1
(ET-1) has a wide variety of biological effects on various tissues and
cell types (Yanagisawa et al., 1988
; Masaki, 1993
) that are mediated by
specific heterotrimeric guanine nucleotide-binding protein (G
protein)-coupled receptor subtypes, the
endothelinA receptor (ETAR)
and endothelinB receptor
(ETBR) (Arai et al., 1990
; Sakurai et al., 1990
).
The two receptors activate multiple subtypes of G proteins and can be
distinguished by their selective coupling with specific G protein
subtypes. When expressed in Chinese hamster ovary (CHO) cells,
ETAR couples with members of the
Gq and Gs families and
stimulates phospholipase C (PLC) and adenylyl cyclase.
ETBR couples with members of the
Gq and Gi families, stimulates PLC, and inhibits adenylyl cyclase (Aramori and Nakanishi, 1992
; Takagi et al., 1995
).
ETAR and ETBR were shown to
be palmitoylated at a cluster of cysteine residues located in the
cytoplasmic tail (Horstmeyer et al., 1996
; Okamoto et al., 1997
). The
functional role of palmitoylation and the cytoplasmic tail domain
downstream of the palmitoylation site in coupling with G proteins has
been studied for ETAR and ETBR (Horstmeyer et al., 1996
; Okamoto et al.,
1997
). We found that in the case of ETBR,
palmitoylation is necessary for coupling with both
Gq and Gi, whereas the
cytoplasmic tail downstream of the palmitoylation sites is also
required for coupling with Gi (Okamoto et al.,
1997
). On the other hand, with ETAR,
palmitoylation is reported to be essential for coupling with
Gq but not with Gs, based
solely on an experiment using an unpalmitoylated mutant ETAR (Horstmeyer et al., 1996
). Thus, which
domain of ETAR is necessary for coupling with
Gs and which of the potential palmitoylation sites is necessary for coupling with Gq remains
unknown. In this context, we first attempted to determine the
structural basis essential for coupling ETAR with
Gq and Gs by focusing on
several potential palmitoylation sites and the cytoplasmic tail
downstream of the palmitoylation sites. For this purpose, we
constructed CHO cells that stably expressed an unpalmitoylated mutant
(Cys383Cys385-388
Ser383Ser385-388)
ETAR (CHO-SerETAR) and a
series of truncated ETARs that lacked the
cytoplasmic tail downstream of any of the five cysteine residues (Cys383Cys385-388).
ET receptors were demonstrated to couple with the
G12 subfamily, consisting of
G12 and G13, in NIH 3T3
cells (Mao et al., 1998
). The G12 subfamily has
been shown to mediate important signaling pathways such as for
Rho/Rho-associated coiled-coil-forming protein kinase (ROCK)-dependent
formation of actin stress fibers (Buhl et al., 1995
) and vascular
smooth muscle cell contraction (Gohla et al., 2000
). These reports
suggest that the G12 subfamily may play important
roles in several ET-1-induced vascular disorders, such as stroke or
vasospasm. Thus, the control of G12 subfamily activation may become a new treatment strategy for these conditions. Recently, it was shown that activation of ETAR
induces actin stress-fiber formation via G12 but
not G13 (Gohla et al., 1999
). However, the domains in the ETAR that are necessary for
coupling with G12 have not yet been elucidated.
The second purpose of the present study is to reveal a functional
coupling between ETAR and
G12/G13 in CHO-ETAR and the functional roles of the
palmitoylation site and cytoplasmic tail downstream of the
palmitoylation site of ETAR in coupling of the
receptor with G12 using mutated
ETARs. Furthermore, the conclusion with regard to
coupling of ETAR with G12
is based on an experiment in which actin stress-fiber formation is lost after expression of a dominant negative mutant of
G12 in fibroblast cell lines derived from
Gq/G11-double deficient
mice (Gohla et al., 1999
). It remains unknown whether ET-1-induced
actin stress-fiber formation requires other G proteins such as
Gq and Gs in addition to
G12. We have attempted to address this point
using CHO cells expressing mutated ETARs.
Previous reports demonstrated that CHO cells express both
G12 and G13 (van de
Westerlo et al., 1995
; Malek et al., 2001
).
| |
Materials and Methods |
|---|
|
|
|---|
Mutagenesis.
The entire coding sequence of human
ETAR was subcloned into pGEM-T. The truncated
ETAR cDNAs shown in Fig.
1 were created by polymerase chain
reaction. The sequence of the oligonucleotide 5'-primers for all
mutants was 5'-CTCGAGGTCGACGGTATCGATAAGCTTGATAT-3'. The sequences of
the oligonucleotide 3'-primers for
388,
385,
383, and
382
were 5'-GCGGCCGCTCAACAGCAGCAGCAGAGGCAT-3',
5'-GCGGCCGCTCA-GCAGAGGCATGACTGGAAA-3', 5'-GCGGCCGCTCAGAGGCATGACTGGAAACAA-3', and
5'-GCGGCCGCTCATGACTGGAAACAATTTTTA-3', respectively. Each 3'-primer
contained one nucleotide substitution to introduce a termination stop
codon with a NotI restriction site, whereas the 5'-primer
contained an XhoI restriction site. Fragments were amplified
by the 5'-primer and each 3'-primer from ETAR
cDNA as a template. The polymerase chain reaction amplification profiles were denaturation at 94°C for 1 min, primer annealing at
55°C for 30 s, and extension at 72°C for 1 min for 30 cycles. The mutations were confirmed by sequencing, and cDNA fragments were
subcloned into a XhoI/NotI restriction site of a
mammalian expression vector pME18Sf predigested by XhoI and
NotI.
|
Cell Culture and Transfection. CHO cells were maintained in Ham's F-12 medium supplemented with 10% fetal calf serum (FCS) under a humidified 5% CO2/95% air atmosphere. For stable expression, CHO cells were transfected with expression plasmids together with pSVbsrr using LipofectAMINE (Invitrogen, Tokyo, Japan). Cell populations expressing the bsrr gene product were selected in Ham's F-12 supplemented with 10% FCS containing blasticidine (10 µg/ml), and clonal cell lines were isolated by colony lifting and maintained in the same medium.
125I-ET-1 Binding Assay.
Assays using
intact cells or membrane preparations were performed exactly as
described previously (Sakamoto et al., 1993
).
Cyclic AMP Formation and Inositol Phosphates Formation.
Cyclic AMP formation and inositol phosphate (IP) formation were
determined as described previously (Okamoto et al., 1997
).
Microinjection.
Microinjection was performed as described
previously (Okazawa et al., 1998
). Briefly, cells were seeded onto
glass coverslips coated with fibronectin (Iwaki Glass, Chiba, Japan),
which were marked with a cross to facilitate the localization of
injected cells and incubated overnight in Ham's F-12 medium containing 1% FCS. Plasmids (100 ng/µl) encoding for
G12G228A and G13G225A were
microinjected into cell nuclei. As a control, expression plasmids
without inserts were microinjected in an adjacent field on the same
coverslip. Microinjection was performed using a manual microinjection
system (Eppendorf-5 Prime, Inc., Hamburg, Germany) equipped with an
Axiovert 100 inverted microscope (Carl-Zeiss GmbH, Frankfurt, Germany).
Stress-Fiber Formation. After incubation of cells with serum-free Ham's F-12 medium for 24 h, ET-1 was added at 37°C for 5 min. Cells were washed three times with phosphate-buffered saline (PBS) and fixed with 4% paraformaldehyde in PBS at room temperature for 15 min. After being washed five times with PBS containing 0.1% Triton X-100 (PBS-Tx), the cells were incubated with fluorescein rhodamine-phalloidin (Molecular Probes, Eugene, OR) in PBS-Tx (1:200) at room temperature for 10 min. After being washed five times with PBS-Tx, the labeled cells were mounted on glass slides and examined with an MRC 1024 laser-scanning confocal microscope (Bio-Rad, Hercules, CA) equipped with an Axiovert 135 M inverted microscope (Carl-Zeiss GmbH).
Images were converted to PICT files in Adobe Photoshop (Adobe Systems Inc., San Jose, CA) and analyzed using NIH Image software (http://rsb.info.nih.gov/nih-image/) by quantifying the average pixel intensities as described previously (Barnett et al., 1997Drugs. Y-27632 was kindly provided by Welfide Corporation (Osaka, Japan). Chemicals were obtained from the following sources: ET-1 from the Peptide Institute (Osaka, Japan), 125I-ET-1 and myo-[3H]inositol from Amersham Biosciences UK, Ltd. (Little Chalfont, Buckinghamshire, UK), rhodamine-phalloidin from Molecular Probes, U73122 from Funakoshi (Tokyo, Japan), and dibutyryl cAMP from Sigma (St. Louis, MO). All other chemicals were of reagent grade and were obtained commercially.
Statistical Analysis. All results were expressed as mean ± S.E.M. The data were subjected to a two-way analysis of variance, and when a significant F value was encountered, the Newman-Keuls multiple range test was used to test for significant differences between treatment groups. A probability level of P < 0.05 was considered statistically significant.
| |
Results |
|---|
|
|
|---|
Stable Expression of Truncated or Unpalmitoylated Mutant
ETARs in CHO Cells.
By cotransfecting CHO cells with
each expression plasmid and pSVbsrr and then
selecting for resistance against blasticidine, we obtained more than
five individual clonal cell lines that stably expressed each receptor
construct. In CHO cells expressing truncated mutant ETAR, 125I-ET-1 binding
assays on membrane preparations from various clones gave
Kd values of 30 to 120 pM and
Bmax values of 0.7 to 1.4 pmol/mg of
protein. On the other hand, in CHO-SerETAR,
125I-ET-1 binding assays on membrane preparations
from various clones gave Kd values of 50 to
140 pM and Bmax values of 0.8 to 1.7 pmol/mg of protein. Cell clones showing similar levels of receptor
densities were used in the subsequent study. The
Kd and Bmax
values for the receptors expressed on each clone adopted are listed in
Table 1.
|
Formation of IPs and cAMP in CHO Cells Expressing Truncated or
Unpalmitoylated Mutant ETARs after Stimulation with
ET-1.
To reveal the functional significance of the palmitoylation
site and the cytoplasmic tail downstream of the palmitoylation site in
coupling with Gq and Gs, we
tested the abilities of the mutant receptors to stimulate accumulation
of [3H]IPs and cAMP, respectively.
[3H]Palmitic acid was metabolically
incorporated into CHO-ETAR
388 and
CHO-ETAR
385 but not into
CHO-ETAR
383,
CHO-ETAR
382, or
CHO-SerETAR (data not shown).
10 nM (Fig. 2A). In
CHO-ETAR
388 or
CHO-ETAR
385, ET-1 caused a
concentration-dependent stimulation of [3H]IP
accumulation with an EC50 value and a maximum
increase that were comparable with those of
CHO-ETAR (Fig. 2A). In contrast, ET-1 failed to
stimulate [3H]IP accumulation in
CHO-ETAR
383,
CHO-ETAR
382, or
CHO-SerETAR (Fig. 2A).
|
10 nM
(Fig. 2B). ET-1 also stimulated cAMP accumulation in a
concentration-dependent manner in CHO-SerETAR (Fig. 2B). The EC50 value and the maximal effect
of cAMP accumulation in CHO-SerETAR were similar
to those in CHO-ETAR (Fig. 2B). In contrast, ET-1
failed to stimulate cAMP formation in CHO cells expressing all
truncated ETAR (Fig. 2B).
ET-1-Induced Actin Stress-Fiber Formation in
CHO-ETAR.
We attempted to determine the structural
basis for coupling of ETAR with
G12/G13 and subtypes of G
proteins involved in ET-1-induced stress-fiber formation. For these
purposes, we examined the effects of inhibition of either one of the G
protein-mediated signaling cascades by blockers and dominant negative
mutants of G12 or G13 (G12G228A or G13G225A,
respectively) on ET-1-induced actin stress-fiber formation in
CHO-ETAR
385,
CHO-SerETAR, and CHO-ETAR.
Subsequently, we deduced the domains of ETAR that
were critical for coupling with G12, based on the
structure of the mutant ETARs that did not have
the ability to couple to G12.
|
ET-1-Induced Actin Stress-Fiber Formation in
CHO-SerETAR and CHO-ETAR
385.
ET-1
induced stress-fiber formation in CHO-SerETAR, in
which coupling of the receptor with Gs but not
Gq was retained (Fig. 4B). Like CHO-ETAR,
ET-1-induced stress-fiber formation was inhibited by preincubation of
CHO-SerETAR with Y-27632 (Fig. 4C) but was not
affected by preincubation with U73122 or microinjection of
G13G225A (Fig. 4, E and F). Notably, unlike
CHO-ETAR, it was inhibited by microinjection of
G12G228A (Fig. 4D).
|
385, in which coupling of the receptor
with Gq but not Gs was
retained (Fig. 5B). Like
CHO-ETAR, ET-1-induced stress-fiber formation
was inhibited by preincubation of CHO-ETAR
385
with Y-27632 (Fig. 5C) but was not affected by microinjection of
G12G228A or G13G225A (Fig.
5, E-G). Notably, unlike CHO-ETAR, it was
inhibited by preincubation with U73122 (Fig. 5D).
|
| |
Discussion |
|---|
|
|
|---|
125I-ET-1 binding assays on intact CHO cells
expressing the wild-type or truncated ETARs
yielded Kd and
Bmax values within similar ranges (Table
1). These results were consistent with previous data (Hashido et al.,
1993
) and suggest that truncation of the receptor is not essential for
cell surface expression and ligand binding of
ETAR. High affinity binding of ET-1 by the mutant
receptors is a good indication that the overall structure of the
receptor is unchanged by truncation as described earlier (Hashido et
al., 1993
).
As reported previously (Horstmeyer et al., 1996
), with
SerETAR in which a cluster of five cysteine
residues in the cytoplasmic tail as potential palmitoylation sites were
substituted with serine, ET-1 failed to stimulate formation of IPs
(Fig. 2A). In the present study, we extended this finding using
truncated ETARs. The truncated ETARs holding Cys385
(CHO-ETAR
385 and
CHO-ETAR
388) retained the ability to stimulate IP formation, whereas those lacking Cys385
(CHO-ETAR
383 and
CHO-ETAR
382) lost such ability (Fig. 2A). These results taken together strongly indicate that
Cys385 in ETAR is critical
for coupling of ETAR with
Gq and that the cytoplasmic tail downstream of
the palmitoylation site is not necessary for this coupling (Fig.
6).
|
In the present study, ET-1 stimulated adenylyl cyclase in
CHO-SerETAR, which lacked potential
palmitoylation sites but retained the cytoplasmic tail (Fig. 2B). These
results are consistent with a previous report (Horstmeyer et al.,
1996
). In contrast, ET-1 failed to stimulate adenylyl cyclase in all
truncated ETARs lacking the cytoplasmic tail,
regardless of the absence or presence of palmitoylation sites of
ETAR (Fig. 2B). These results, taken together, strongly demonstrate that the cytoplasmic tail of
ETAR is critical for coupling with
Gs, although it is not necessary for coupling with Gq (Fig. 6). Moreover, it was previously
demonstrated that the second and third intracellular loops of
ETAR were major determinants of the selective
coupling of ETAR with Gs
(Takagi et al., 1995
). Therefore, we conclude that both the cytoplasmic
tail and the second and third intracellular loops of
ETAR are necessary for coupling of
ETAR with Gs.
Next, we attempted to identify the subtypes of G proteins that are
involved in ET-1-induced stress-fiber formation using
CHO-ETAR
385, CHO-SerETAR, and CHO-ETAR.
Based on sensitivity to Y-27632, the Rho/ROCK pathway plays important
roles in ET-1-induced stress-fiber formation in
CHO-ETAR (Fig. 5C) as in NIH 3T3 cells and
fibroblasts (Mao et al., 1998
; Gohla et al., 1999
). ET-1-induced
stress-fiber formation in CHO-ETAR was affected
by neither pretreatment with U73122 nor microinjection of
G12G228A or G13G225A (Fig.
5F) but was inhibited by combined treatment with U73122 and
G12G228A microinjection (Fig. 3D). These results
indicate that ET-1-induced stress-fiber formation is mediated via two
signaling pathways (i.e., the Gq/PLC- and
G12-dependent pathways in
CHO-ETAR) (Fig. 6) and also that only one of the
two is sufficient for actin stress-fiber formation. Moreover, the
present study indicates that Gs is not involved
in ET-1-induced stress-fiber formation, because dibutyryl cAMP failed
to induce actin stress-fiber formation in
CHO-ETAR (Fig. 3E).
These conclusions are supported by findings obtained with SerETAR. That is, because SerETAR does not couple with Gq, which is one of the two signaling pathways necessary for ET-1-induced stress-fiber formation, blockade of another signaling pathway with G12G228A leads to inhibition of actin stress-fiber formation. Furthermore, these results indicate that SerETAR retains the ability to couple with G12.
In CHO-ETAR
385, in which coupling of the
receptor with Gq but not Gs
is retained, ET-1-induced stress-fiber formation was inhibited by
U73122 but not G12G228A. Based on the conclusion obtained from wild-type ETAR, these data can be
interpreted to mean that because ETAR
385 lacks
coupling with G12, which is one of the two
signaling pathways necessary for ET-1-induced actin stress-fiber
formation, blockade of another signaling pathway with U73122 leads to
inhibition of actin stress-fiber formation. Therefore, these results
indicate that ETAR
385 has lost the ability to
couple with G12, although it can still induce
stress-fiber formation via the Gq-dependent pathway.
Finally, we deduced the structural determinant for coupling of
ETAR with G12 based on data
from experiments using mutated ETARs. That is,
loss of coupling of ETAR
385 with
G12 and retention of coupling of
SerETAR with G12 clearly
show that the cytoplasmic tail downstream of
Cys385 but not the palmitoylation site of
ETAR is essential for coupling with
G12.
In conclusion, the present study showed that 1) the cytoplasmic tail downstream of the palmitoylation site of ETAR is essential for coupling with Gs and G12, 2) Cys385 of ETAR is critical for coupling with Gq, and 3) the signal for ET-1-induced stress-fiber formation is mediated via the Gq/PLC- and G12-dependent pathway to Rho/ROCK system in CHO-ETAR. Thus, the presence of one of the two pathways is sufficient for stress-fiber formation.
| |
Acknowledgments |
|---|
We thank Mitsubishi Pharma Corporation for the kind donation of Y-27632.
| |
Footnotes |
|---|
Received July 31, 2001; Accepted October 11, 2001
This work was supported by a grant-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan; by Special Coordination Funds for Science and Technology from the Science and Technology Agency; by a Research Grant for Cardiovascular Disease (11C-1) from the Ministry of Health and Welfare; and by a grant from the Smoking Research Foundation, Japan.
Yoshifumi Kawanabe, M.D., Department of Neurosurgery, Kyoto University Faculty of Medicine, 54 Shougoin-Kawaharachou, Sakyo-ku, Kyoto 6060-8507, Japan. E-mail: kawanabe{at}kuhp.kyoto-u.ac.jp
| |
Abbreviations |
|---|
ET-1, endothelin-1;
ETAR, endothelinA receptor;
ETBR, endothelinB receptor;
CHO, Chinese hamster ovary;
PLC, phospholipase C;
ROCK, Rho-associated coiled-coil-forming protein
kinase;
CHO-ETAR, Chinese hamster ovary cells that stably
express human endothelinA receptor;
CHO-ETAR
Cys x, Chinese hamster ovary
cells that express human endothelinA receptor truncated at
the carboxyl-terminal downstream of Cys x (in which
x is 382, 383, 385, or 388);
CHO-SerETAR, Chinese hamster ovary cells that express an unpalmitoylated
(Cys383Cys385-388
Ser383Ser385-388)
human endothelinA receptor;
G12G228A, dominant
negative mutant of G12;
G13G225A, dominant
negative mutant of G13;
FCS, fetal calf serum;
IP, inositol
phosphate;
PBS, phosphate-buffered saline;
PBS-Tx, phosphate-buffered
saline containing 0.1% Triton X-100;
Y-27632, (R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide;
U73122, 1-(6-{[17
-3-methoxyestra-1,3.5(10)-trien-17-yl]
amino}hexyl)-1H-pyrrole-2,5-dione.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Morigi, S. Buelli, C. Zanchi, L. Longaretti, D. Macconi, A. Benigni, D. Moioli, G. Remuzzi, and C. Zoja Shigatoxin-Induced Endothelin-1 Expression in Cultured Podocytes Autocrinally Mediates Actin Remodeling Am. J. Pathol., December 1, 2006; 169(6): 1965 - 1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawanabe, N. Hashimoto, and T. Masaki Characterization of G proteins involved in activation of nonselective cation channels and arachidonic acid release by norepinephrine/{alpha}1A-adrenergic receptors Am J Physiol Cell Physiol, March 1, 2004; 286(3): C596 - C600. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawanabe, K. Nozaki, N. Hashimoto, and T. Masaki Characterization of Ca2+ Channels and G Proteins Involved in Arachidonic Acid Release by Endothelin-1/EndothelinA Receptor Mol. Pharmacol., September 1, 2003; 64(3): 689 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, R. M. McCarron, S. Golech, J. Bembry, B. Ford, F. A. Lenz, N. Azzam, and M. Spatz ET-1- and NO-mediated signal transduction pathway in human brain capillary endothelial cells Am J Physiol Cell Physiol, February 1, 2003; 284(2): C243 - C249. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawanabe, N. Hashimoto, and T. Masaki Effects of Phosphoinositide 3-Kinase on the Endothelin-1-Induced Activation of Voltage-Independent Ca2+ Channels and Mitogenesis in Chinese Hamster Ovary Cells Stably Expressing EndothelinA Receptor Mol. Pharmacol., September 1, 2002; 62(3): 756 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawanabe, Y. Okamoto, S. Miwa, N. Hashimoto, and T. Masaki Molecular Mechanisms for the Activation of Voltage-Independent Ca2+ Channels by Endothelin-1 in Chinese Hamster Ovary Cells Stably Expressing Human EndothelinA Receptors Mol. Pharmacol., July 1, 2002; 62(1): 75 - 80. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||